Target intelligence / Profile preview

Mycobacterium tuberculosis Antigen Mtb32A (Mtb32A)

Target: Mtb32A
Molecular classification: Serine protease, Antigen

Overview

Mtb32A is a secreted protein antigen from *Mycobacterium tuberculosis* involved in stimulating T-cell mediated immunity. It is a serine protease family member and a promising candidate for subunit vaccines against TB.

Mechanism of action

Not applicable, targeted for vaccine development; potential protease inhibition if directly targeted with a drug.

Biological functions

Immune responseT-cell activationPotential role in bacterial virulence

Disease associations

InfectionTuberculosis

Safety considerations

Potential for off-target effects if protease activity is targeted by a drug.

Biomarkers

Exposure to M. tuberculosis (PPD positivity)

Beyond the preview

Go deeper on Mycobacterium tuberculosis Antigen Mtb32A (Mtb32A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis Antigen Mtb32A (Mtb32A).

Explore the full profile